Skip to content
Screener

Globus Medical GMED Total Liabilities & Equity

Total Liabilities & Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$201.06B+4.0%
Stryker logo
StrykerSYK
$47.93B+3.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$873.02M+4.3%
Boston Scientific logo
Boston ScientificBSX
$44.35B+10.5%
IAR
Integra LifeSciencesIART
$3.56B-2.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$22.8B-0.3%

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands, except share and per share values)June 30, 2026December 31, 2025
Equity:
Class A common stock; $0.001 par value. Authorized 500,000,000 shares; issued and outstanding 111,822,190 and 112,625,126 shares at June 30, 2026 and December 31, 2025, respectively112113
Class B common stock; $0.001 par value. Authorized 275,000,000 shares; issued and outstanding 22,430,097 and 22,430,097 shares at June 30, 2026 and December 31, 2025, respectively2222
Additional paid-in capital3,230,1863,169,812
Accumulated other comprehensive income/(loss)11,19615,346
Retained earnings1,527,0871,387,957
Total equity4,768,6034,573,250
Total liabilities and equity$5,488,258$5,302,761

Item 1. Financial Statements

FAQ

What is Globus Medical's total liabilities & equity?
Globus Medical (GMED) reported total liabilities & equity of $5.49B in Q2 2026.
How has Globus Medical's total liabilities & equity changed year-over-year?
Globus Medical's total liabilities & equity increased by 10.6% year-over-year, from $4.96B to $5.49B.
What is the long-term trend for Globus Medical's total liabilities & equity?
Over 5 years (2020 to 2025), Globus Medical's total liabilities & equity has grown at a 25.9% compound annual growth rate (CAGR), from $1.68B to $5.3B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Globus Medical's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude